{"count": 13, "results": [{"_id": "31896527", "pmid": 31896527, "pmcid": "PMC6940647", "title": "Metformin Treatment for Diabetes Mellitus Correlates with Progression and Survival in Colorectal Carcinoma", "journal": "Transl Oncol", "authors": ["Powell MK", "Cempirkova D", "Dundr P", "Grimmichova T", "Trebicky F", "E Brown R", "Gregorova J", "Litschmannova M", "Janurova K", "Pesta M", "Heneberg P"], "date": "2020-02-01T00:00:00Z", "doi": "10.1016/j.tranon.2019.10.011", "meta_date_publication": "2020 Feb", "meta_volume": "13", "meta_issue": "2", "meta_pages": "383-392", "score": 50281.39, "text_hl": "Survival in @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ subgroup was longer, particularly in @SPECIES_9606 @@@men@@@ with @<m>DISEASE_Colonic_Neoplasms</m> @DISEASE_MESH:D003110 @@@CRC@@@. ", "citations": {"NLM": "Powell MK, Cempirkova D, Dundr P, Grimmichova T, Trebicky F, E Brown R, Gregorova J, Litschmannova M, Janurova K, Pesta M, Heneberg P. Metformin Treatment for Diabetes Mellitus Correlates with Progression and Survival in Colorectal Carcinoma Transl Oncol. 2020 Feb;13(2):383-392. PMID: 31896527", "BibTeX": "@article{31896527, title={Metformin Treatment for Diabetes Mellitus Correlates with Progression and Survival in Colorectal Carcinoma}, author={Powell MK and Cempirkova D and Dundr P and Grimmichova T and Trebicky F and E Brown R and Gregorova J and Litschmannova M and Janurova K and Pesta M and Heneberg P}, journal={Transl Oncol}, volume={13}, number={2}, pages={383-392}}"}}, {"_id": "35452877", "pmid": 35452877, "pmcid": "PMC9096669", "title": "Metformin-induced reductions in tumor growth involves modulation of the gut microbiome ", "journal": "Mol Metab", "authors": ["Broadfield LA", "Saigal A", "Szamosi JC", "Hammill JA", "Bezverbnaya K", "Wang D", "Gautam J", "Tsakiridis EE", "Di Pastena F", "McNicol J", "Wu J", "Syed S", "Lally JSV", "Raphenya AR", "Blouin MJ", "Pollak M", "Sacconi A", "Blandino G", "McArthur AG", "Schertzer JD", "Surette MG", "Collins SM", "Bramson JL", "Muti P", "Tsakiridis T", "Steinberg GR"], "date": "2022-07-01T00:00:00Z", "doi": "10.1016/j.molmet.2022.101498", "meta_date_publication": "2022 Jul", "meta_volume": "61", "meta_issue": "", "meta_pages": "101498", "score": 50247.195, "text_hl": "@SPECIES_10090 @@@Mice@@@ with syngeneic @CELLLINE_CVCL:B288 @@@MC38@@@ @<m>DISEASE_Colonic_Neoplasms</m> @DISEASE_MESH:D003110 @@@colon adenocarcinomas@@@ were treated with @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ or feces obtained from control or @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ treated @SPECIES_10090 @@@mice@@@.", "citations": {"NLM": "Broadfield LA, Saigal A, Szamosi JC, Hammill JA, Bezverbnaya K, Wang D, Gautam J, Tsakiridis EE, Di Pastena F, McNicol J, Wu J, Syed S, Lally JSV, Raphenya AR, Blouin MJ, Pollak M, Sacconi A, Blandino G, McArthur AG, Schertzer JD, Surette MG, Collins SM, Bramson JL, Muti P, Tsakiridis T, Steinberg GR. Metformin-induced reductions in tumor growth involves modulation of the gut microbiome  Mol Metab. 2022 Jul;61():101498. PMID: 35452877", "BibTeX": "@article{35452877, title={Metformin-induced reductions in tumor growth involves modulation of the gut microbiome }, author={Broadfield LA and Saigal A and Szamosi JC and Hammill JA and Bezverbnaya K and Wang D and Gautam J and Tsakiridis EE and Di Pastena F and McNicol J and Wu J and Syed S and Lally JSV and Raphenya AR and Blouin MJ and Pollak M and Sacconi A and Blandino G and McArthur AG and Schertzer JD and Surette MG and Collins SM and Bramson JL and Muti P and Tsakiridis T and Steinberg GR}, journal={Mol Metab}, volume={61}, pages={101498}}"}}, {"_id": "31699708", "pmid": 31699708, "title": "Bisphosphonates Zometa and Fosamax Synergize with Metformin to Prevent AOM-Induced Colon Cancer in F344 Rat Model.", "journal": "Cancer Prev Res (Phila)", "authors": ["Madka V", "Kumar G", "Pathuri G", "Zhang Y", "Lightfoot S", "Asch AS", "Mohammed A", "Steele VE", "Rao CV"], "date": "2020-02-01T00:00:00Z", "doi": "10.1158/1940-6207.CAPR-19-0265", "meta_date_publication": "2020 Feb", "meta_volume": "13", "meta_issue": "2", "meta_pages": "185-194", "score": 50245.363, "text_hl": "Overall, our results suggest that the combination of low doses of @CHEMICAL_Zoledronic_Acid @CHEMICAL_MESH:D000077211 @@@zometa@@@ or @CHEMICAL_Alendronate @CHEMICAL_MESH:D019386 @@@fosamax@@@ with @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ showed synergistic effect and significantly inhibited @<m>DISEASE_Colonic_Neoplasms</m> @DISEASE_MESH:D003110 @@@colon adenocarcinoma@@@ incidence and multiplicity.", "citations": {"NLM": "Madka V, Kumar G, Pathuri G, Zhang Y, Lightfoot S, Asch AS, Mohammed A, Steele VE, Rao CV. Bisphosphonates Zometa and Fosamax Synergize with Metformin to Prevent AOM-Induced Colon Cancer in F344 Rat Model. Cancer Prev Res (Phila). 2020 Feb;13(2):185-194. PMID: 31699708", "BibTeX": "@article{31699708, title={Bisphosphonates Zometa and Fosamax Synergize with Metformin to Prevent AOM-Induced Colon Cancer in F344 Rat Model.}, author={Madka V and Kumar G and Pathuri G and Zhang Y and Lightfoot S and Asch AS and Mohammed A and Steele VE and Rao CV}, journal={Cancer Prev Res (Phila)}, volume={13}, number={2}, pages={185-194}}"}}, {"_id": "37738800", "pmid": 37738800, "title": "Diclofenac and metformin synergistic dose dependent inhibition of hamster fibrosarcoma, rescued with mebendazole.", "journal": "Biomed Pharmacother", "authors": ["Popović DJ", "Popović KJ", "Miljković D", "Popović JK", "Lalošević D", "Poša M", "Dolićanin Z", "Čapo I"], "date": "2023-09-20T00:00:00Z", "doi": "10.1016/j.biopha.2023.115528", "meta_date_publication": "2023 Sep 20", "meta_volume": "167", "meta_issue": "", "meta_pages": "115528", "score": 50242.816, "text_hl": "Furthermore, @CHEMICAL_Diclofenac @CHEMICAL_MESH:D004008 @@@diclofenac@@@ with @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ demonstrated antiproliferative effects in hamster @DISEASE_Fibrosarcoma @DISEASE_MESH:D005354 @@@fibrosarcoma@@@ @CELLLINE_CVCL:1915 @@@BHK-21/C13@@@, human @DISEASE_Lung_Neoplasms @DISEASE_MESH:D008175 @@@lung carcinoma@@@ @CELLLINE_CVCL:0023 @@@A549@@@ (@CELLLINE_CVCL:M023 @@@CCL-185@@@), @<m>DISEASE_Colonic_Neoplasms</m> @DISEASE_MESH:D003110 @@@colon carcinoma@@@ @CELLLINE_CVCL:0320 @@@HT-29@@@ (@CELLLINE_CVCL:A8FQ @@@HTB-38@@@) and @DISEASE_Uterine_Cervical_Neoplasms @DISEASE_MESH:D002583 @@@cervical carcinoma@@@ @CELLLINE_CVCL:0030 @@@HeLa@@@ (@CELLLINE_CVCL:M023 @@@CCL-2@@@) cell cultures, with markedly lower @DISEASE_Drug_Related_Side_Effects_and_Adverse_Reactions @DISEASE_MESH:D064420 @@@cytotoxicity@@@ in the normal fetal lung @CELLLINE_CVCL:0440 @@@MRC-5@@@ cells. ", "citations": {"NLM": "Popović DJ, Popović KJ, Miljković D, Popović JK, Lalošević D, Poša M, Dolićanin Z, Čapo I. Diclofenac and metformin synergistic dose dependent inhibition of hamster fibrosarcoma, rescued with mebendazole. Biomed Pharmacother. 2023 Sep 20;167():115528. PMID: 37738800", "BibTeX": "@article{37738800, title={Diclofenac and metformin synergistic dose dependent inhibition of hamster fibrosarcoma, rescued with mebendazole.}, author={Popović DJ and Popović KJ and Miljković D and Popović JK and Lalošević D and Poša M and Dolićanin Z and Čapo I}, journal={Biomed Pharmacother}, volume={167}, pages={115528}}"}}, {"_id": "27411816", "pmid": 27411816, "title": "Metformin inhibits development of colon malignant tumors induced by 1,2-dimethylhydrazine in rats.", "journal": "Dokl Biol Sci", "authors": ["Bekusova VV", "Patsanovskii VM", "Nozdrachev AD", "Anisimov VN"], "date": "2016-05-01T00:00:00Z", "doi": "10.1134/S0012496616030017", "meta_date_publication": "2016 May", "meta_volume": "468", "meta_issue": "1", "meta_pages": "97-100", "score": 50062.207, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ inhibits development of @<m>DISEASE_Colonic_Neoplasms</m> @DISEASE_MESH:D003110 @@@colon malignant tumors@@@ induced by @CHEMICAL_1_2_Dimethylhydrazine @CHEMICAL_MESH:D019813 @@@1,2-dimethylhydrazine@@@ in @SPECIES_10116 @@@rats@@@.", "citations": {"NLM": "Bekusova VV, Patsanovskii VM, Nozdrachev AD, Anisimov VN. Metformin inhibits development of colon malignant tumors induced by 1,2-dimethylhydrazine in rats. Dokl Biol Sci. 2016 May;468(1):97-100. PMID: 27411816", "BibTeX": "@article{27411816, title={Metformin inhibits development of colon malignant tumors induced by 1,2-dimethylhydrazine in rats.}, author={Bekusova VV and Patsanovskii VM and Nozdrachev AD and Anisimov VN}, journal={Dokl Biol Sci}, volume={468}, number={1}, pages={97-100}}"}}, {"_id": "20813708", "pmid": 20813708, "title": "[Effects of metformin on proliferation of human colon carcinoma cell line SW-480].", "journal": "Nan Fang Yi Ke Da Xue Xue Bao", "authors": ["Zhou XZ", "Xue YM", "Zhu B", "Sha JP"], "date": "2010-08-01T00:00:00Z", "meta_date_publication": "2010 Aug", "meta_volume": "30", "meta_issue": "8", "meta_pages": "1935-8, 1942", "score": 50062.18, "text_hl": "[Effects of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ on proliferation of @SPECIES_9606 @@@human@@@ @<m>DISEASE_Colonic_Neoplasms</m> @DISEASE_MESH:D003110 @@@colon carcinoma@@@ cell line @CELLLINE_CVCL:0546 @@@SW-480@@@].", "citations": {"NLM": "Zhou XZ, Xue YM, Zhu B, Sha JP. [Effects of metformin on proliferation of human colon carcinoma cell line SW-480]. Nan Fang Yi Ke Da Xue Xue Bao. 2010 Aug;30(8):1935-8, 1942. PMID: 20813708", "BibTeX": "@article{20813708, title={[Effects of metformin on proliferation of human colon carcinoma cell line SW-480].}, author={Zhou XZ and Xue YM and Zhu B and Sha JP}, journal={Nan Fang Yi Ke Da Xue Xue Bao}, volume={30}, number={8}, pages={1935-8, 1942}}"}}, {"_id": "29308089", "pmid": 29308089, "title": "Survival benefits in colorectal adenocarcinoma with the use of metformin among a black diabetic inner city population.", "journal": "Colorectal Cancer", "authors": ["Zhu RC", "Rattanakorn K", "Pham S", "Mallam D", "McIntyre T", "Salifu MO", "Youssef I", "McFarlane SI", "Vignesh S"], "date": "2017-01-01T00:00:00Z", "doi": "10.2217/crc-2017-0001", "meta_date_publication": "2017", "meta_volume": "6", "meta_issue": "1", "meta_pages": "33-41", "score": 50062.14, "text_hl": "Survival benefits in @<m>DISEASE_Colonic_Neoplasms</m> @DISEASE_MESH:D003110 @@@colorectal adenocarcinoma@@@ with the use of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ among a black @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetic@@@ inner city population.", "citations": {"NLM": "Zhu RC, Rattanakorn K, Pham S, Mallam D, McIntyre T, Salifu MO, Youssef I, McFarlane SI, Vignesh S. Survival benefits in colorectal adenocarcinoma with the use of metformin among a black diabetic inner city population. Colorectal Cancer. 2017;6(1):33-41. PMID: 29308089", "BibTeX": "@article{29308089, title={Survival benefits in colorectal adenocarcinoma with the use of metformin among a black diabetic inner city population.}, author={Zhu RC and Rattanakorn K and Pham S and Mallam D and McIntyre T and Salifu MO and Youssef I and McFarlane SI and Vignesh S}, journal={Colorectal Cancer}, volume={6}, number={1}, pages={33-41}}"}}, {"_id": "30854043", "pmid": 30854043, "pmcid": "PMC6365932", "title": "Metformin-activated AMPK regulates beta-catenin to reduce cell proliferation in colon carcinoma RKO cells", "journal": "Oncol Lett", "authors": ["Park SY", "Kim D", "Kee SH"], "date": "2019-03-01T00:00:00Z", "doi": "10.3892/ol.2019.9892", "meta_date_publication": "2019 Mar", "meta_volume": "17", "meta_issue": "3", "meta_pages": "2695-2702", "score": 50056.01, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@-activated @GENE_PRKAA1 @GENE_5562 @@@AMPK@@@ regulates @GENE_CTNNB1 @GENE_477032 @@@beta-catenin@@@ to reduce cell proliferation in @<m>DISEASE_Colonic_Neoplasms</m> @DISEASE_MESH:D003110 @@@colon carcinoma@@@ @CELLLINE_CVCL:0504 @@@RKO@@@ cells", "citations": {"NLM": "Park SY, Kim D, Kee SH. Metformin-activated AMPK regulates beta-catenin to reduce cell proliferation in colon carcinoma RKO cells Oncol Lett. 2019 Mar;17(3):2695-2702. PMID: 30854043", "BibTeX": "@article{30854043, title={Metformin-activated AMPK regulates beta-catenin to reduce cell proliferation in colon carcinoma RKO cells}, author={Park SY and Kim D and Kee SH}, journal={Oncol Lett}, volume={17}, number={3}, pages={2695-2702}}"}}, {"_id": "29456855", "pmid": 29456855, "title": "Metformin and aspirin treatment could lead to an improved survival rate for Type 2 diabetic patients with stage II and III colorectal adenocarcinoma relative to non-diabetic patients.", "journal": "Mol Clin Oncol", "authors": ["De Monte A", "Brunetti D", "Cattin L", "Lavanda F", "Naibo E", "Malagoli M", "Stanta G", "Bonin S"], "date": "2018-03-01T00:00:00Z", "doi": "10.3892/mco.2018.1554", "meta_date_publication": "2018 Mar", "meta_volume": "8", "meta_issue": "3", "meta_pages": "504-512", "score": 50055.95, "text_hl": "The findings support the hypothesis of a possible inhibitory effect of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ and @CHEMICAL_Aspirin @CHEMICAL_MESH:D001241 @@@ASA@@@ on @<m>DISEASE_Colonic_Neoplasms</m> @DISEASE_MESH:D003110 @@@CRC@@@ cells. ", "citations": {"NLM": "De Monte A, Brunetti D, Cattin L, Lavanda F, Naibo E, Malagoli M, Stanta G, Bonin S. Metformin and aspirin treatment could lead to an improved survival rate for Type 2 diabetic patients with stage II and III colorectal adenocarcinoma relative to non-diabetic patients. Mol Clin Oncol. 2018 Mar;8(3):504-512. PMID: 29456855", "BibTeX": "@article{29456855, title={Metformin and aspirin treatment could lead to an improved survival rate for Type 2 diabetic patients with stage II and III colorectal adenocarcinoma relative to non-diabetic patients.}, author={De Monte A and Brunetti D and Cattin L and Lavanda F and Naibo E and Malagoli M and Stanta G and Bonin S}, journal={Mol Clin Oncol}, volume={8}, number={3}, pages={504-512}}"}}, {"_id": "28443209", "pmid": 28443209, "pmcid": "PMC5365186", "title": "Metformin prevents hormonal and metabolic disturbances and 1,2-dimethylhydrazine-induced colon carcinogenesis in non-diabetic rats", "journal": "Cancer Biol Med", "authors": ["Bekusova VV", "Patsanovskii VM", "Nozdrachev AD", "Trashkov AP", "Artemenko MR", "Anisimov VN"], "date": "2017-02-01T00:00:00Z", "doi": "10.20892/j.issn.2095-3941.2016.0088", "meta_date_publication": "2017 Feb", "meta_volume": "14", "meta_issue": "1", "meta_pages": "100-107", "score": 50054.375, "text_hl": "The two @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@MF@@@ doses did not affect @<m>DISEASE_Colonic_Neoplasms</m> @DISEASE_MESH:D003110 @@@colon carcinoma@@@ incidence in @SPECIES_10116 @@@rat@@@ rectums and descending colons. ", "citations": {"NLM": "Bekusova VV, Patsanovskii VM, Nozdrachev AD, Trashkov AP, Artemenko MR, Anisimov VN. Metformin prevents hormonal and metabolic disturbances and 1,2-dimethylhydrazine-induced colon carcinogenesis in non-diabetic rats Cancer Biol Med. 2017 Feb;14(1):100-107. PMID: 28443209", "BibTeX": "@article{28443209, title={Metformin prevents hormonal and metabolic disturbances and 1,2-dimethylhydrazine-induced colon carcinogenesis in non-diabetic rats}, author={Bekusova VV and Patsanovskii VM and Nozdrachev AD and Trashkov AP and Artemenko MR and Anisimov VN}, journal={Cancer Biol Med}, volume={14}, number={1}, pages={100-107}}"}}]}